MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...

A high-level overview of MS Emerging Markets Debt Fund (MSD). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.

Hover over Tap a data point to see when it was last updated. Median values are calculated based on data over a 12 month period. Data is provided by CoreLogic. CoreLogic is a leading provider of ...

Hover over Tap a data point to see when it was last updated. Median values are calculated based on data over a 12 month period. Data is provided by CoreLogic. CoreLogic is a leading provider of ...